Medical News

RSS

Liberator Medical Holdings closes private placement of 4.66M common stock shares

Liberator Medical Holdings, Inc. announces today the closing of a private placement of 4,666,667 shares of its common stock for gross proceeds of $7.0 million on March 9, 2010, to a single institutional investor. Littlebanc Advisors, LLC. acted as the sole placement agent and financial advisor to the Company. Liberator's Board of Directors unanimously approved the transaction. As part of the transaction, the institutional investor has the right to add a member of its choice to Liberator Medical's Board of Directors.

11 Mar 2010

Genetic mutation in African-American men with family history of prostate cancer discovered

Shahriar Koochekpour, MD, PhD, Assistant Professor of Microbiology and Immunology, Biochemistry and Molecular Biology, and Genetics at LSU Health Sciences Center New Orleans, led research that has discovered, for the first time, a genetic mutation in African-American men with a family history of prostate cancer who are at increased risk for the disease.

11 Mar 2010

GOP putting strategies in place to thwart Dems on reform

"When Mitch McConnell speaks these days, he expects House Blue Dogs to be listening." The Senate minority leader is "very much part of a newly launched Republican shadow war to block health care reform by playing on the nerves of wavering Democrats across the Capitol" with "his real goal of sowing doubts about the fiscal soundness of President Barack Obama's agenda — and with it health care reform.

11 Mar 2010

Chelsea Therapeutics announces financial results for fourth quarter 2009

Chelsea Therapeutics International, Ltd. reported financial results for the fourth quarter and full year 2009 and will host a conference call this afternoon at 4:30 PM ET to discuss these results and provide a quarterly update on the Company's development progress.

11 Mar 2010

Cardiologists to highlight capabilities of InfraReDx' LipiScan Coronary Imaging System at ACC.10 and i2 Summit

InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company's LipiScan™ Coronary Imaging System will be highlighted in multiple sessions during the 59th Annual Scientific Session of the American College of Cardiology.

11 Mar 2010

Senate poised to pass COBRA subsidy extension, Medicare 'doc fix'

The Senate is set to vote Wednesday on a jobs bill that would extend the COBRA subsidy program and Medicaid funding for states and prevent a Medicare reimbursement cut for doctors.

11 Mar 2010

NeuroSearch's MermaiHD study supports potential Huntington's disease modifying properties of Huntexil

NeuroSearch today announced that further analysis of the data from the MermaiHD study with Huntexil(R) (pridopidine) for the treatment of Huntington's disease supports potential disease modifying properties of the drug.

11 Mar 2010

Cogent Healthcare, Seton Medical Center to develop exclusive hospitalist care delivery system

Cogent Healthcare today announced a new hospital medicine affiliation with 375-bed Seton Medical Center, located in Daly City, Calif., and the Daly City Hospitalist Medical Group, an existing Seton physician group, to develop a distinctive hospitalist care delivery system.

11 Mar 2010

Lithera announces positive results from Phase IIa clinical study of LIPO-102

Lithera, Inc. today announced positive results from a Phase IIa clinical study of LIPO-102, its novel injectable combination of salmeterol xinafoate (SX) and fluticasone propionate (FP) for selective, non-ablative fat reduction.

11 Mar 2010

Regence Blueshield acquires Seattle-based health and wellness company

Maveron LLC, a Seattle-based venture capital firm focused on helping exceptional entrepreneurs build great consumer businesses, announced the asset acquisition of portfolio company Kinetix Living Corp. by Regence BlueShield of Washington. Terms of the transaction were not disclosed.

11 Mar 2010

HyperBranch Medical Technology's surgical sealants to be marketed under new name – Adherus Surgical Sealants

HyperBranch Medical Technology, Inc. announced today that it will begin to market their surgical sealants under a new product identity – Adherus Surgical Sealants.

11 Mar 2010

GSK to offer flexible drug pricing in middle-income countries

Drug maker GlaxoSmithKline (GSK) "plans to bolster earnings by selling to more people in middle-income countries after cutting prices in the world's poorest nations," Bloomberg/BusinessWeek reports.

11 Mar 2010

2010 AAOS meeting highlights advancements in back and spine treatment options

Approximately 21 million visits were made to physicians' offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions –including injury, herniated discs and the deterioration of the vertebrae.

11 Mar 2010

Eureka Genomics announces closing of $3.7M private financing round

Eureka Genomics today announced the closing of a $3.7 million private financing round whose participants included private individuals and undisclosed angel investors. The proceeds will further discovery research aimed at identifying novel microorganisms associated with specific cancers and other important diseases, as well as help grow Eureka Genomics’ high-throughput sequencing and bioinformatics service business on a global basis.

11 Mar 2010

Heartbeat Digital's revenue for fiscal year 2009 increases by 25%

Heartbeat Digital, a New York-based interactive agency, reported 25% revenue growth in the 2009 fiscal year.

10 Mar 2010

Senate passes extension of COBRA and other unemployment benefits

The Hill: Six Senate Republicans joined most Democrats to approve a package of unemployment aid and tax provisions. The bill, which its backers say is "a necessary step during the economic recovery," passed on a 62-36 vote. "The bulk of the bill's cost -- about $80 billion -- goes toward prolonging increased levels of federal unemployment aid and COBRA healthcare benefits for the jobless through the end of December." The measure's remaining cost would extend "the current rate of Medicare payments to doctors, which is scheduled to see a 21 percent rate cut" as well as a number of tax breaks.

10 Mar 2010

Positive results from Limerick BioPharma's LIM-0705 Phase 1a trial

Limerick BioPharma, Inc., a developer of innovative therapies that help cells pump unwanted or toxic substances away from vulnerable tissues, has announced positive results of a Phase 1a trial for its lead compound, LIM-0705, which has completed its first in man study.

10 Mar 2010

Patients who undergo gastric bypass surgery increase their risk of developing kidney stones

Patients who undergo gastric bypass surgery experience changes in their urine composition that increase their risk of developing kidney stones, research from UT Southwestern Medical Center investigators suggests.

10 Mar 2010

CPRIT grants $6.8 million for cancer prevention programs

The Cancer Prevention and Research Institute of Texas today awarded over $6.8 million to fund twelve new cancer prevention programs through local clinics, health districts, community-based organizations, and academic institutions across the state of Texas.

10 Mar 2010

Five facts about Obama's proposed changes to Medicare payroll tax

Kaiser Health News staff writer Christopher Weaver outlines some key issues, starting with: "Should affluent Americans have to pay Medicare payroll tax on their investment income?

10 Mar 2010